These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29954707)

  • 1. Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain.
    Arango C; Baeza I; Bernardo M; Cañas F; de Dios C; Díaz-Marsá M; García-Portilla MP; Gutiérrez-Rojas L; Olivares JM; Rico-Villademoros F; Rodríguez-Jiménez R; Sánchez-Morla EM; Segarra R; Crespo-Facorro B
    Rev Psiquiatr Salud Ment (Engl Ed); 2019; 12(2):92-105. PubMed ID: 29954707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness.
    Llorca PM; Abbar M; Courtet P; Guillaume S; Lancrenon S; Samalin L
    BMC Psychiatry; 2013 Dec; 13():340. PubMed ID: 24359031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM
    Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Decision-Making in the Treatment of Schizophrenia: Focus on Long-Acting Injectable Antipsychotics.
    Samalin L; Garnier M; Auclair C; Llorca PM
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Patterns, Healthcare Resource Utilization and Costs Among Schizophrenia Patients Treated with Long-Acting Injectable Versus Oral Antipsychotics.
    Shah A; Xie L; Kariburyo F; Zhang Q; Gore M
    Adv Ther; 2018 Nov; 35(11):1994-2014. PubMed ID: 30269292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
    Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
    Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives.
    Iyer S; Banks N; Roy MA; Tibbo P; Williams R; Manchanda R; Chue P; Malla A
    Can J Psychiatry; 2013 May; 58(5 Suppl 1):23S-9S. PubMed ID: 23945064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes of European physicians towards the use of long-acting injectable antipsychotics.
    Patel MX; Bent-Ennakhil N; Sapin C; di Nicola S; Loze JY; Nylander AG; Heres S
    BMC Psychiatry; 2020 Mar; 20(1):123. PubMed ID: 32169077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicians' attitudes toward the use of long-acting injectable antipsychotics.
    Samalin L; Charpeaud T; Blanc O; Heres S; Llorca PM
    J Nerv Ment Dis; 2013 Jul; 201(7):553-9. PubMed ID: 23817151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients".
    Jackson JW; Fulchino L; Rogers J; Mogun H; Polinski J; Henderson DC; Schneeweiss S; Fischer MA
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):95-104. PubMed ID: 29168261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long acting injectable antipsychotics in the treatment of schizophrenia: a review of literature].
    Graffino M; Montemagni C; Mingrone C; Rocca P
    Riv Psichiatr; 2014; 49(3):115-23. PubMed ID: 25000887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral versus long-acting antipsychotics on social functioning: A psychiatrists' survey in India.
    Gundugurti PR; Nagpal R; Sheth A; Narang P; Gawande S; Singh V
    Asian J Psychiatr; 2017 Dec; 30():88-93. PubMed ID: 28843143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of antipsychotic treatment type and regimen on the functionality of patients with schizophrenia.
    Acosta FJ; Chinea E; Hernández JL; Rodríguez F; García-Bello M; Medina G; Nieves W
    Nord J Psychiatry; 2014 Apr; 68(3):180-8. PubMed ID: 23672274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and nurses.
    Geerts P; Martinez G; Schreiner A
    BMC Psychiatry; 2013 Feb; 13():58. PubMed ID: 23414331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninterventional, Naturalistic, Retrospective Study to Describe Prescription Patterns of Long-Acting Injectable Antipsychotics and the Impact of Introducing a New Atypical Antipsychotic in the Spanish Province of Tarragona Catchment Area.
    Gaviria AM; Franco J; Rico G; Muntané G; Sáez C; Sánchez-Gistau V; de Pablo J; Vilella E
    Prim Care Companion CNS Disord; 2017 Mar; 19(2):. PubMed ID: 28346773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-Based Expert Consensus Regarding Long-Acting Injectable Antipsychotics for Schizophrenia from the Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN).
    Yang KC; Liao YT; Yang YK; Lin SK; Liang CS; Bai YM
    CNS Drugs; 2021 Aug; 35(8):893-905. PubMed ID: 34312788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of long acting injectable antipsychotic use and associated clinical factors in schizophrenia among 15 Asian countries and region.
    Tang CT; Chua EC; Chew QH; He YL; Si TM; Chiu HF; Xiang YT; Kato TA; Kanba S; Shinfuku N; Lee MS; Park SC; Park YC; Chong MY; Lin SK; Yang SY; Tripathi A; Avasthi A; Grover S; Kallivayalil RA; Udomratn P; Chee KY; Tanra AJ; Rabbani MG; Javed A; Kathiarachchi S; Waas D; Myint WA; Sartorius N; Tran VC; Nguyen KV; Tan CH; Baldessarini RJ; Sim K
    Asia Pac Psychiatry; 2020 Dec; 12(4):e12393. PubMed ID: 32468725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers to long-acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey.
    Oguchi Y; Miyake N; Ando K
    Neuropsychopharmacol Rep; 2024 Jun; 44(2):417-423. PubMed ID: 38634351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of attitudes toward long-acting injectable antipsychotics among psychiatrists and patients.
    Kim SW; Lee YH; Jang JE; Yoo T; Kim JM; Shin IS; Yoon JS
    Int Clin Psychopharmacol; 2013 Mar; 28(2):80-6. PubMed ID: 23325306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.
    Gaviria AM; Franco JG; Aguado V; Rico G; Labad J; de Pablo J; Vilella E
    PLoS One; 2015; 10(10):e0139403. PubMed ID: 26427051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.